Infu-Tech Launches Smartmedsmobile.com

Wireless Medical Reminders, Targeted News and Health Information Directly

To People Over Their Wireless Devices



Apr 17, 2001, 01:00 ET from Infu-Tech, Inc.

    CARLSTADT, N.J., April 17 /PRNewswire/ -- Smartmeds.com, Inc. a subsidiary
 of Infu-Tech, Inc. (Nasdaq:   INFU), a leading provider of specialty
 pharmaceuticals, announces the launch of the first phase of its
 Smartmedsmobile.com wireless application featuring personalized medication
 alerts. Activation of future phases are expected to include health news,
 targeted medical information and e-commerce capabilities.
     Smartmedsmobile.com connects individuals via their Internet enabled
 wireless phone to a unique service that will empower them to better manage
 their health via a customized program developed to facilitate their daily drug
 and disease management requirements.  Subscriber information about this new
 interactive wireless health service is available at
 http://www.smartmedsmobile.com.
     This first phase of the initial launch of the Smartmedsmobile.com program
 provides Smartmeds.com, Inc. with the ability to generate revenues from
 membership in a customized program.  Revenue streams in the future phases, are
 expected to be generated from advertising, sales of prescription refills, and
 revenue from airtime for wireless device usage.  This four-prong revenue
 stream is projected to expand income opportunities as the company seeks to
 empower people to improve compliance with their individualized medical, health
 and drug protocols.
     "Smartmeds.com, believes that people who take a drug, be it aspirin or
 heart medication on a regular daily basis, will more readily comply with
 prescribed medicine protocols if easily alerted at the time for their next
 dosage, no matter when or where they may be.  With non-compliance having a
 major impact on the unnecessary escalation of a disease or condition,
 enrollment in Smartmedsmobile.com is designed to remind users to take their
 medications as per their doctor's orders," said Smartmeds.com CEO, Daniel
 Rosen.
     Early entry into a consumer controlled wireless environment,
 Smartmedsmobile.com is bridging the gap in communication with a
 patient-directed wireless device connecting doctors and family members
 anytime, anyplace.  The program enables people to design a program around
 their particular condition or disease, and to keep them involved in
 maintaining their own health regimens.
     "We live in an age where social interaction, e-commerce and entertainment
 are all accessed via wireless instruments.  Smartmedsmobile.com can offer
 those people who regularly take some form of medication or supplement,
 invaluable assistance.  Being compliant with medical drug and disease
 management programs is a life-saving extension to this wireless communication
 universe," said Chairman and CEO of Infu-Tech Jack Rosen.
 
     About Infu-Tech/SmartMeds.com
     Infu-Tech is a leading provider of specialty pharmaceuticals and medical
 services.  With more than 15 years clinical experience and managed care
 relationships with the enrollees of HMOs, large employer groups, Medicare and
 Medicaid, Infu-Tech has earned a reputation for patient satisfaction and
 clinically proven success in delivering high levels of service to special
 needs patients.  Infu-Tech has extended its company's interaction with
 patients via its http://www.smartmeds.com website and Smartmedsmobile.com
 wireless initiative.  The Smartmeds.com website includes an online pharmacy,
 interaction with medical professionals, and facilitates the ordering of
 specialty medications and other medical products.  Infu-Tech is accredited by
 the Joint Commission on Accreditation of Health Care Organizations (JCAHO),
 and the company's products and services are marketed nationally, Infu-Tech is
 a publicly traded company, NASDAQ SMALLCAP: INFU.
 
     Certain statements contained in this release are forward-looking.
 Although Infu-Tech, Inc. believes that its expectations are based on
 reasonable assumptions within the bounds of its knowledge of its business and
 operations, there can be no assurance that actual results will not differ
 materially from its expectations.  Factors that could cause actual results to
 differ from expectations include the difficulty in controlling healthcare
 costs.  Integrating new operations from acquired companies and the possible
 negative effects of prospective healthcare reform.  For other important
 factors that may cause actual results to differ materially from expectations
 and underlying assumptions, see reports by Infu-Tech, Inc. filed with the
 Securities and Exchange Commission.
 
 

SOURCE Infu-Tech, Inc.
    CARLSTADT, N.J., April 17 /PRNewswire/ -- Smartmeds.com, Inc. a subsidiary
 of Infu-Tech, Inc. (Nasdaq:   INFU), a leading provider of specialty
 pharmaceuticals, announces the launch of the first phase of its
 Smartmedsmobile.com wireless application featuring personalized medication
 alerts. Activation of future phases are expected to include health news,
 targeted medical information and e-commerce capabilities.
     Smartmedsmobile.com connects individuals via their Internet enabled
 wireless phone to a unique service that will empower them to better manage
 their health via a customized program developed to facilitate their daily drug
 and disease management requirements.  Subscriber information about this new
 interactive wireless health service is available at
 http://www.smartmedsmobile.com.
     This first phase of the initial launch of the Smartmedsmobile.com program
 provides Smartmeds.com, Inc. with the ability to generate revenues from
 membership in a customized program.  Revenue streams in the future phases, are
 expected to be generated from advertising, sales of prescription refills, and
 revenue from airtime for wireless device usage.  This four-prong revenue
 stream is projected to expand income opportunities as the company seeks to
 empower people to improve compliance with their individualized medical, health
 and drug protocols.
     "Smartmeds.com, believes that people who take a drug, be it aspirin or
 heart medication on a regular daily basis, will more readily comply with
 prescribed medicine protocols if easily alerted at the time for their next
 dosage, no matter when or where they may be.  With non-compliance having a
 major impact on the unnecessary escalation of a disease or condition,
 enrollment in Smartmedsmobile.com is designed to remind users to take their
 medications as per their doctor's orders," said Smartmeds.com CEO, Daniel
 Rosen.
     Early entry into a consumer controlled wireless environment,
 Smartmedsmobile.com is bridging the gap in communication with a
 patient-directed wireless device connecting doctors and family members
 anytime, anyplace.  The program enables people to design a program around
 their particular condition or disease, and to keep them involved in
 maintaining their own health regimens.
     "We live in an age where social interaction, e-commerce and entertainment
 are all accessed via wireless instruments.  Smartmedsmobile.com can offer
 those people who regularly take some form of medication or supplement,
 invaluable assistance.  Being compliant with medical drug and disease
 management programs is a life-saving extension to this wireless communication
 universe," said Chairman and CEO of Infu-Tech Jack Rosen.
 
     About Infu-Tech/SmartMeds.com
     Infu-Tech is a leading provider of specialty pharmaceuticals and medical
 services.  With more than 15 years clinical experience and managed care
 relationships with the enrollees of HMOs, large employer groups, Medicare and
 Medicaid, Infu-Tech has earned a reputation for patient satisfaction and
 clinically proven success in delivering high levels of service to special
 needs patients.  Infu-Tech has extended its company's interaction with
 patients via its http://www.smartmeds.com website and Smartmedsmobile.com
 wireless initiative.  The Smartmeds.com website includes an online pharmacy,
 interaction with medical professionals, and facilitates the ordering of
 specialty medications and other medical products.  Infu-Tech is accredited by
 the Joint Commission on Accreditation of Health Care Organizations (JCAHO),
 and the company's products and services are marketed nationally, Infu-Tech is
 a publicly traded company, NASDAQ SMALLCAP: INFU.
 
     Certain statements contained in this release are forward-looking.
 Although Infu-Tech, Inc. believes that its expectations are based on
 reasonable assumptions within the bounds of its knowledge of its business and
 operations, there can be no assurance that actual results will not differ
 materially from its expectations.  Factors that could cause actual results to
 differ from expectations include the difficulty in controlling healthcare
 costs.  Integrating new operations from acquired companies and the possible
 negative effects of prospective healthcare reform.  For other important
 factors that may cause actual results to differ materially from expectations
 and underlying assumptions, see reports by Infu-Tech, Inc. filed with the
 Securities and Exchange Commission.
 
 SOURCE  Infu-Tech, Inc.